The overexpression of HDAC6 in CRC, its role in promoting tumor growth through regulation of the MAPK/ERK signaling pathway, and its effect on patient survival indicate the oncogenic potential of HDAC6 in this malignancy. This evidence concerns the gene HDAC6 and colorectal carcinoma.